Skip to main content

Table 3 Albumin redox of patients and healthy subjects

From: Improvement of the fraction of human mercaptalbumin on hemodialysis treatment using hydrogen-dissolved hemodialysis fluid: a prospective observational study

      

(%) mean ± SD

 
 

EWHD2014 (n = 12)

EWHD2015 (n = 12)

C-HD (n = 38)

Healthy subjects (n = 24)

 

Pre-HD

Post-HD

Pre-HD

Post-HD

Pre-HD

Post-HD

f(HMA)

51.32 ± 5.63

72.04 ± 5.73

58.03 ± 7.43

76.42 ± 4.67

51.07 ± 9.07

70.53 ± 8.05

79.11 ± 5.46

f(HNA)

48.68 ± 5.63

27.96 ± 5.73

41.97 ± 7.43

23.58 ± 4.67

48.93 ± 9.07

29.47 ± 8.05

20.89 ± 5.46

  1. f(HMA) fraction of human mercaptalbumin, f(HNA) fraction of human nonmercaptalbumin
  2. f(HNA) = 100 − f(HMA)
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us